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Abstract
Background: The testis-specific isoform of angiotensin-converting enzyme (tACE) is exclusively expressed in germ
cells during spermatogenesis. Although the exact role of tACE in male fertility is unknown, it clearly plays a critical
function in spermatogenesis. The dipeptidase domain of tACE is identical to the C-terminal catalytic domain of
somatic ACE (sACE). Bradykinin potentiating peptides (BPPs) from snake venoms are the first natural sACE inhibitors
described and their structure–activity relationship studies were the basis for the development of antihypertensive
drugs such as captopril. In recent years, it has been showed that a number of BPPs – including BPP-10c – are able
to distinguish between the N- and C-active sites of sACE, what is not applicable to captopril. Considering the
similarity between tACE and sACE (and since BPPs are able to distinguish between the two active sites of sACE), the
effects of the BPP-10c and captopril on the structure and function of the seminiferous epithelium were characterized
in the present study. BPP-10c and captopril were administered in male Swiss mice by intraperitoneal injection
(4.7 μmol/kg for 15 days) and histological sections of testes were analyzed. Classification of seminiferous tubules
and stage analysis were carried out for quantitative evaluation of germ cells of the seminiferous epithelium. The
blood-testis barrier (BTB) permeability and distribution of claudin-1 in the seminiferous epithelium were analyzed
by hypertonic fixative method and immunohistochemical analyses of testes, respectively.
Results: The morphology of seminiferous tubules from animals treated with BPP-10c showed an intense disruption
of the epithelium, presence of atypical multinucleated cells in the lumen and degenerated germ cells in the adluminal
compartment. BPP-10c led to an increase in the number of round spermatids and total support capacity of Sertoli cell
in stages I, V, VII/VIII of the seminiferous epithelium cycle, without affecting BTB permeability and the distribution
of claudin-1 in the seminiferous epithelium. Interestingly, no morphological or morphometric alterations were
observed in animals treated with captopril.
Conclusions: The major finding of the present study was that BPP-10c, and not captopril, modifies spermatogenesis
by causing hyperplasia of round spermatids in stages I, V, and VII/VIII of the spermatogenic cycle.
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Background
Spermatogenesis takes place in the seminiferous epithe-
lium of the mammalian testis. The germ cells residing in
the basal compartment must traverse the blood-testis
barrier (BTB) and enter the adluminal compartment for
further development into round, elongated spermatids
[1]. The inter-Sertoli tight junctions (TJ) constitute the
BTB that protects the seminiferous epithelium from in-
vasion by molecules or cells that may disturb the process
of spermatogenesis. At the same time, this permeability
barrier needs to be temporarily removed at particular
stages of spermatogenesis for the movement of germ cells
across the seminiferous epithelium [2]. TJ is a multimolec-
ular membrane that comprises integral membrane pro-
teins, including occludin and claudin family proteins [2,3].
Testis-specific isoform of angiotensin-converting enzyme
(tACE) is exclusively expressed in maturing germ cells
and spermatozoa, but not in Sertoli cells, Leydig cells or
any other somatic cell in male adults, suggesting that it is
related to the spermiogenesis process [4-7]. Experimental
evidence using tACE knockout models (−/−) indicates
that this enzyme is directly associated with male fertility,
but its exact role remains unknown [5,8-11]. It has been
reported that tACE is able to release the extracellular
portion of glycosylphosphatidylinositol (GPI)-anchored
proteins, and it is directly and specifically implicated in
egg fertilization by the sperm, independent of its peptidase
activity [12,13].
Somatic angiotensin I-converting enzyme (sACE) is a
well-characterized zinc dipeptidyl carboxypeptidase that
plays a pivotal role in the regulation of blood pressure
by converting angiotensin I into angiotensin II and by
inactivating bradykinin [14]. sACE has two highly hom-
ologous active sites, one at the C-domain and another
at the N-domain, each of which is catalytically active
and functionally independent [15]. tACE is distinguish-
able from sACE because it has only the active site of
the C-domain, preceded by an additional N-terminal
sequence [16].
Bradykinin potentiating peptides (BPPs) from Bothrops
jararaca snakes were the first natural sACE inhibitors
described. Studies of their structure–activity relationships
were the basis for the development of antihypertensive
drugs, such as captopril [17]. Typically, BPPs contain 5
to 13 amino acid residues with a pyroglutamyl residue
(<E) at the N-terminus and a proline residue at the C-
terminus. BPPs longer than seven amino acids share
similar features, including a high content of proline
residues and the tripeptide sequence Ile–Pro–Pro at
the C-terminus [18].
We found that BPP-10c (<ENWPHPQIPP) is able to
distinguish between the two domains of sACE and
displays distinct hypotensive effects on rats [19,20]. In
addition, among other BPPs from snake venom, BPP-
10c is the most selective inhibitor for the active site at
the C-domain of sACE (Ki(app) = 0.5 nM) [19]. Captopril,
for instance, is 2.8-orders of magnitude less effective
than BPP-10c as an inhibitor of the C-site of sACE
[21]. In recent years, we have supported the hypothesis
that diverse biological functions for each BPP could be
mediated by different interactions with alternative targets,
including that BPP-10c is internalized by HUVEC,
HEK293 and C6 cells [22-25]. These results are not
surprising, considering that BPP-10c is a proline-rich
peptide, a feature that endows this molecule with the
properties of cell-penetrating peptides and resistance to
proteolysis.
Considering the structural similarity between the C-
domain of sACE and tACE, it was observed that tACE
male knockout mice were severely hypofertile, tACE was
exclusively expressed in maturing germ cells, BPP-10c had
selectivity for the active site at the C-domain of sACE
and it could be internalized by different cells, and ACE
inhibitors could affect the function of the seminiferous
epithelium, particularly spermiogenesis [5,7,9,18,22,24,25].
Although the in vitro nanomolar range inhibition of hu-
man tACE by BPP-5a (<EKWAP) and BPP-9a (<EWPRP-
QIPP) has been reported, there are no reports on the
possible effects of BPPs in the structure and function of
the seminiferous epithelium [26]. Thus, the aim of the
current study was to compare the effect of BPP-10c
and captopril on spermatogenesis in male mice in order
to evaluate the morphological and morphometric pa-
rameters, distribution of claudin-1 and analysis of BTB
permeability in the seminiferous epithelium.
Methods
Animals
Male Swiss mice (weighting 30 to 35 g) were bred at the
Butantan Institute (São Paulo, Brazil). Animals were
housed at a temperature of 22°C, had access to water
and food ad libitum, and were subjected to a light–dark
cycle (12 hours each). The experimental protocols were
performed in accordance with the guidelines of the
Butantan Institute for the humane use of laboratory ani-
mals and were approved by local authorities (protocol
number 369/07).
Reagents
All chemicals were of analytical reagent grade, purchased
from Calbiochem-Novabiochem Corp. (USA), Merck
(USA) and Sigma–Aldrich Corp. (USA) for peptide syn-
thesis; captopril and bradykinin were purchased from
Sigma Chemical Co (USA).
Peptide synthesis
BPP-10c (<ENWPHPQIPP) was synthesized using auto-
mated solid-phase synthesis via Fmoc (9-fluorenylmethy-
Gilio et al. Journal of Venomous Animals and Toxins including Tropical Diseases 2013, 19:28 Page 2 of 9
http://www.jvat.org/content/19/1/28
loxycarbonyl) strategy [23]. The final deprotected peptide
was purified by semi-preparative HPLC using an Econosil
C-18 column (10 μm, 22.5 mm × 250 mm) and a two-
solvent system: (A) TFA/H2O (1:1000) and (B) TFA/ACN/
H2O (1:900:100). The column was eluted at a flow rate
of 5 mL/minute over 20 minutes with a 10 to 50% gra-
dient of solvent B, and the effluent was detected with
an SPD-10AV Shimadzu UV–vis detector, monitored by
absorbance at 220 nm. The molecular weight and purity
of synthetic peptide were checked via MALDI-TOF mass
spectrometry using an Ettan MALDI-TOF/Pro system
(Amersham Biosciences, Sweden) and cinnamic acid as a
matrix. The peptide concentration was determined by
amino acid analysis after acid hydrolysis in vacuum-sealed
tubes at 110°C for 22 hours with HCl 6 N containing 1%
phenol. Samples were subjected to amino acid analysis
using a pico Tag station.
Treatment of animals with BPP-10c and captopril
Male adult mice (30–35 g) were assigned to groups (five
animals per group) and treated for 15 days (once a day)
by intraperitoneal injection with 4.7 μmol/kg/day of
BPP-10c or captopril, diluted in 100 μL of 0.91% w/v
aqueous sodium chloride solution. The control group
consisted of treatment with vehicle only. The dose of
BPP-10c used in the experiments was in agreement with
Silva et al. [23]. Mice were killed by CO2 asphyxiation
after treatment and testes were collected for morpho-
logical, morphometric and immunohistochemical ana-
lyses of seminiferous epithelium. BTB permeability
studies were carried out in mice treated with BPP-10c,
captopril (the same dose, 4.7 μmol/kg/day), lipopoly-
saccharide (LPS, 166 μmol/kg/day – positive control) or
vehicle (0.91% w/v aqueous sodium chloride solution –
negative control) for 15 days. All treatments and exper-
iments were performed in duplicate or triplicate.
Morphological and morphometric analyses
The testes of mice treated with BPP-10c, captopril or
vehicle were immediately immersed and fixed in Bouin’s
solution for 24 hours. The samples were dehydrated in
ethanol, and embedded in ParaplastW (Sigma Chemical
Figure 1 Morphological analysis of the seminiferous epithelium of male adult mice treated with BPP-10c and captopril. Photomicrographs
of the seminiferous tubules of male adult mice treated with vehicle (A), captopril (B) and BPP-10c (C, D, E, F) using Mallory’s trichrome stain.
The seminiferous tubule morphological data obtained from the animals treated with BPP-10c indicated the presence of atypical cells in the
lumen (arrow), disruption of the epithelium (*), and a loss of elongated spermatids (#). No alteration was observed in the seminiferous epithelium from
mice treated with captopril or vehicle.
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Co., USA) and sectioned at 4 μm thickness. Histological
sections were stained with periodic acid-Schiff ’s (PAS) with
Harris hematoxylin counterstaining (for morphometric
analysis), or Mallory's trichrome stain (for morphological
analysis). Images were taken using a Pixera camera (Pixera
Corporation, USA) mounted on a Zeiss Axioskop 2 photo-
microscope and captured with a Intel PentiumW computer
using Adobe Photoshop 7.0.1 (Adobe Systems, USA).
The stages of the seminiferous epithelium cycle were
characterized based on the development of the acroso-
mic system and morphology of the developing spermatid
nucleus [27]. Four spermatogenic stages (I, V, VII/VIII,
and XII), representing beginning, middle and end of sem-
iniferous epithelium cycle were chosen for quantitative
evaluation [28]. Four round or nearly-round seminiferous
tubule cross-sections per animal were randomly selected
for each spermatogenic stage and the following parameters
were measured: epithelium height, tubule diameter and
lumen diameter using NIH image software (developed
at the U.S. National Institutes of Health and available
at http://rsb.info.nih.gov/nih-image). The germ cell nuclei
(type A spermatogonia; type B spermatogonia; prelepto-
tene spermatocyte; zygotene spermatocyte; meiotic figures;
secondary spermatocyte; pachytene spermatocyte; round
spermatid) and Sertoli cell nucleoli present at stages I, V,
VII/VIII, and XII of the seminiferous epithelium cycle
were counted using Adobe Photoshop 7.0.1. Total support
capacity of each Sertoli cell was obtained by the ratios
of total number of germ cells to total number Sertoli
cell nucleoli for each stage.
Distribution of claudin-1 by immunohistochemistry
Testis sections from mice treated with BPP-10c, captopril
or vehicle were processed according to the Streptavidin-
Biotin-peroxidase Complex (SBC) protocol. After deparaffi-
nization and dehydration, the sections were pretreated with
0.03% H2O2 for 30 minutes, at room temperature, to
block endogenous peroxidase activity. Samples were
then washed in phosphate-buffered saline pH 7.4 (PBS),
two times for 5 minutes each, and immersed in a solution
containing 5% fat-free dry milk (Molico, NestléW) in PBS
for 15 minutes to block non-specific binding sites.
Sections were incubated overnight at 4°C with anti-
rabbit claudin-1 antiserum (MH25- Zymed/InvitrogenW,
lot 50393527, cat. no. 71–7800) diluted (1:250) in 0.05
M Tris–HCl with 1% bovine serum albumin (BSA). They
were washed in PBS three times for 5 minutes and incu-
bated with the diluted biotinylated anti-rabbit IgG for 30
minutes, then washed in PBS three times for 5 minutes
and incubated for 30 minutes with Streptavidin-biotin-
peroxidase complex. Immunoreactive sites were revealed
using a buffered solution of 3,3’-diaminobenzidine–tet-
rahydrochloride (DAB) (Dako cytomationW, USA). The
sections were dehydrated, mounted and analyzed in a
Zeiss Axioskop 2 photomicroscope and the images were
captured by Pixera (Pixera Corporation, USA). As negative
control, normal rabbit IgG (Vector Laboratories) was used
instead of the first antibody in every experiment. Hema-
toxylin was used for counterstaining. We also performed
immunoblot analysis of mouse testis lysate to assess the
specificity of anti-rabbit claudin-1 antibody.
Analysis of BTB by hypertonic fixative method
Mice treated with BPP-10c, captopril, LPS or vehicle were
perfused with a hypertonic fixative of 5% glutaraldehyde,
0.05 M sodium cacodylate, and 10% dextrose [29]. Testes
were removed and fixed by immersion in hypertonic fixa-
tive for 2 hours at 4°C. The testes were washed in 0.05 M
sodium cacodylate buffer for 10 minutes, cut in half trans-
versely, post-fixed in 1% osmium tetroxide, and embedded
Table 1 Quantitative analysis of germinal cells in male adult mouse seminiferous epithelium treated with vehicle (C),
captopril (CAP) or BPP-10c (10c)
Germinal
cells
Stages
I V VII/VIII XII
C 10c CAP C 10c CAP C 10c CAP C 10c CAP
SC 4.0 ± 0.8 4.7 ± 0.5 5.0 ± 0.8 4.5 ± 0.5 4.2 ± 0.9 5.0 ± 0.9 5.2 ± 0.5 4.7 ± 0.9 5.1 ± 0.4 5.2 ± 0.5 5.5 ± 0.5 5.8 ± 0.9
SPG(A) 3.5 ± 0.5 4.0 ± 0.5 4.6 ± 0.9
SPG(B) 5.2 ± 0.5 4.5 ± 0.5 5.5 ± 0.5
SP(Pl) 13.2 ± 0.5 13.0 ± 0.8 12.7 ± 1.2
SP(Z) 12.2 ± 0.5 11.0 ± 0.8 12.4 ± 1.5
MF 9.7 ± 0.5 9.0 ± 0.5 8.9 ± 0.8
SS 6.2 ± 0.5 5.2 ± 0.9 5.1 ± 0.9
SP(P) 10.5 ± 0.5 10.0 ± 0.8 10.9 ± 1.0 12.0 ± 0.8 12.2 ± 0.8 13.0 ± 1.2 19.2 ± 0.5 19.0 ± 0.8 20.1 ± 1.5
RP 14.0 ± 0.8 27.0 ± 0.9* 15.0 ± 1.8 14.7 ± 0.5 19.0 ± 0.8* 15.7 ± 0.9 15.0 ± 0.8 30.0 ± 0.8* 16.2 ± 0.8
C: control; 10c: BPP-10c; CAP: captopril; SC: Sertoli cell; SPG(A): type A spermatogonia; SPG(B): type B spermatogonia; SP (Pl, Z, P): spermatocyte (preleptotene
zygotene, pachytene); MF: meiotic figures; SS: secondary spermatocyte; RP: round spermatid.
Values are the means ± SEM. Significant difference from the C and CAP values p < 0.01 (*).
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in ParaplastW following standard procedures. Half-μm-thick
sections were stained with hematoxylin and eosin.
Statistical analysis
All statistical evaluations were performed either by
one-way analysis of variance (ANOVA) followed by the
Bonferroni range test or by Student’s t-test (GraphPad
Prism 4.0, GraphPad Software, Incorporation). The cri-
teria for statistical significance were set at p < 0.05.
Results
Effect of BPP-10c on the seminiferous epithelium in male
adult mice
The seminiferous tubules observed in animals treated
with vehicle (Figure 1 – A) and captopril (Figure 1 – B)
displayed normal testicular tissue with typical seminiferous
epithelium after 15 days of treatment. In contrast, testes of
animals treated with BPP-10c (Figure 1 – C to F) presented
atypical multinucleated cells in the lumen, degenerated
germ cells in the adluminal compartment, disruption of
the epithelium, and loss of elongated spermatids in the
tubules. No alterations in the number of spermatogonia,
preleptotene spermatocytes, zygotene spermatocytes,
pachytene spermatocytes, or Sertoli cells were detected
after treatment with BPP-10c, captopril or vehicle
(Table 1). However, the treatment with BPP-10c led to
an increase in the number of round spermatids in
stages I, V, VII/VIII (Table 1).
Epithelium height increased and lumen diameter
decreased in the testes of the animals treated with
BPP-10c, but no alteration was detected in the tubule
diameter when compared with vehicle (Figure 2 – A).
Figure 2 Morphometric analysis of the seminiferous epithelium of male adult mice treated with BPP-10c or captopril. (A) Morphometric
aspects of the seminiferous tubules of control and treated animals (epithelium height, tubule diameter and lumen diameter). (B) Total support
capacity of Sertoli cell increased during stages I, V, VII/VIII and XII of the seminiferous epithelium cycle when animals were treated with BPP-10c.
Data are presented as mean ± SEM, and the criteria for statistical significance were set at p < 0.05.
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Furthermore, BPP-10c increased the total support
capacity of Sertoli cell in stages I, V, VII/VIII of the
seminiferous epithelium cycle, but not in stage XII
(Figure 2 – B). Interestingly, no significant differences
were showed in morphometrical parameters analyzed
in the testis of the animals treated with captopril
when compared with vehicle or BPP-10c (Figure 2 –
A and B).
Figure 3 Effects of BPP-10c and captopril on the distribution of claudin-1 in the seminiferous epithelium of adult mouse testis. (A)
Immunoblot analysis of mouse testis lysate using an antibody to claudin-1. (B, C, D) Immunohistochemical staining of mouse testis
transverse cross-sections treated with vehicle. (E) Non-specific staining was detected only in the basal and adluminal compartments of
seminiferous epithelium of control sections – negative control. (F and G) Immunostaining of claudin-1 following treatment with captopril
or (H and I) BPP-10c demonstrated no difference in the distribution of claudin-1 when compared with control. Hematoxylin was used for
counterstaining. Scale bar: 50 μm.
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Immunohistochemical localization of claudin-1 in the
seminiferous epithelium after BPP-10c treatment
Claudin-1 was observed in the mouse testis tissue lysates
through immunoblot analysis using anti-claudin-1 anti-
body, detected as a single band at approximately 20 kDa
(Figure 3–A). The localization of immunoreactive claudin-
1 in the seminiferous epithelium appeared as reddish-
brown precipitate in the basal compartment of normal
mouse seminiferous tubules (Figure 3 – B, C and D). Non-
specific staining was only detected in the seminiferous
epithelium of control sections, illustrating that the im-
munoreactivity is specific for claudin-1 (Figure 3 – E).
Immunoreactive claudin-1 precipitates formed in the
basal and adluminal compartments of each tubule in
every stage of the germinal epithelium cycle. Moreover,
immunoreactive specificity could be observed in the
nucleus of premeiotic germ cells, but not in pachytene
spermatocytes, secondary spermatocytes, or round sper-
matids. Likewise, the distribution of claudin-1 following
captopril (Figure 3 – F and G) and BPP-10c (Figure 3 – H
and I) treatments was the same as that of seminiferous
epithelium in untreated mice.
Analysis of BTB permeability
The barrier can be visualized in testes fixed with a
dextrose-containing hypertonic fixative. The permeability
of BTB was examined in testicular sections of mice treated
with vehicle, captopril, BPP-10c or LPS. Cells directly ex-
posed to the fixative, such as those on the basal side of
the barrier, suffer the osmotic effects of the dextrose
and shrink, leaving large intercellular gaps. Because
dextrose cannot transverse the BTB, cells on the luminal
side are protected from the hypertonicity of the fixative
and maintain close apposition with one another. The
BTB was maintained in testes of mice treated with
vehicle, captopril and BPP-10c (Figure 4 – A, B and C,
respectively, see arrows). However, the barrier was not
intact following LPS treatment and cells throughout
the cross-section of the tubule shrank away from each
other (Figure 4 – D, see arrow). LPS is known to com-
promise testicular function [30].
Discussion
The major finding of the present study was that BPP-10c,
the most potent and selective sACE C-domain inhibitor,
modified spermatogenesis in mice without affecting
BTB permeability or the distribution of claudin-1, a
protein found at the site of the BTB [19]. Interestingly,
captopril, which is also an inhibitor of sACE, did not
show any effect on spermatogenesis probably due to
the inability of this ACE active-site directed inhibitor
to cross the BTB. In fact, it has been described that
sACE inhibitors (captopril and derivates) did not affect
tACE activity in vivo, suggesting that these drugs are
limited in testicular penetration by the BTB [30,31].
Morphologic investigation of testes in adult mice indi-
cated a clear alteration in the seminiferous epithelium
following BPP-10c treatment. Alterations were observed
in stages I, V, VII/VIII in round spermatids, while no such
alterations were observed following captopril treatment.
Figure 4 Maintenance of the blood-testis barrier (BTB) in male adult mice treated with vehicle, captopril or BPP-10c. Photomicrographs
of 0.5-μm thick – plastic-embedded transverse sections of (A) vehicle, (B) captopril, (C) BPP-10c and (D) LPS – of seminiferous tubules following
fixation with hyperosmotic fixative and staining with hematoxylin and eosin. The adluminal meiotic cells are protected from fixative-induced
condensation, maintaining normal morphology and cellular contacts in A, B and C (arrow). The BTB is not maintained in the seminiferous
tubules of mice treated with LPS (D, see arrow).
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The effects of BPP-10c treatment also included an in-
crease in the height of the epithelium and a decrease in
the diameter of the tubule lumen, as well as an increase
in the total support capacity of Sertoli cells, indicating
that BPP-10c inhibited spermiogenesis. In fact, tACE is
only found in round spermatids in the seminiferous
tubules, with levels increasing markedly during further
differentiation [7]. The observed effects of BPP-10c
could be explained by the interaction with tACE, which
causes alterations in its dipeptidase and/or GPI-anchored
protein-releasing activities, leading to an inhibition of
maturation with an increase in the number of round
spermatids.
Claudin-1 expression has been demonstrated in the
testis and culture of mouse Sertoli cells, but we have
shown in the current study for the first time its distribu-
tion in mouse seminiferous epithelium [32]. Other studies
have indicated that claudin-1 expression in the epididy-
mis is not exclusively limited to TJ, but appears along
the entire interface of adjacent epithelial cells, as well
as along the basal plasma membrane [33]. We demon-
strated that claudin-1 is found in the basal and adlum-
inal compartments in the seminiferous epithelium of
normal mice, suggesting that claudin-1 may have func-
tions other than those involving TJ in the testis and
epididymis. Moreover, Gregory et al. [34] identified
claudin-1 in the nucleus as an intracellular signaling
molecule that either diffuses or is actively transported
to the nucleus from the site of cell-cell adhesion by
mitogen-activated protein kinase kinase 2 (MEK2) in
pancreatic cells. MEK2, an isoform of mitogen-activated
protein kinases (MAPKs), is found in all premeiotic germ
cells and spermatocytes, and is implicated in chromatin
condensation during the division of male germ cells [35-37].
In fact, our immunohistochemical studies showed that
claudin-1 is expressed in premeiotic germ cells, with a
pattern similar to that of MEK2 expression. These results
suggest that claudin-1 participates in chromatin condensa-
tion of germ cells by signaling through MEK2.
The localization of claudin-1 in the seminiferous epi-
thelium was examined to assess its possible changes in
the BTB during the BPP-10c-induced spermatogenesis
damage. No alterations were shown in the distribution
of claudin-1 in animals treated with BPP-10c, captopril,
or vehicle, suggesting that the peptide did not alter BTB
integrity. Some chemicals disrupt this barrier and increase
its permeability, but we have shown that treatment with
BPP-10c did not alter BTB permeability, suggesting that
the peptide could cross the BTB and interact with tACE
or others targets [30,38,39]. This hypothesis seems to
represent a real possibility, since a growing number of
peptides, including toxins, have been shown to penetrate
cells [25,40,41]. Besides, we demonstrated that BPP-10c
was internalized by HEK-293 T and HUVEC cells, but the
mechanism is yet unknown and it opens new perspectives
to study their internalization by Sertoli cell culture [23,24].
Conclusion
In summary, this study demonstrated that BPP-10c, a po-
tent selective C-domain inhibitor of ACE from B. jararaca
venom, inhibits spermiogenesis in mice without affecting
the distribution of claudin-1 or the permeability of BTB.
Further analyses will contribute to a better understanding
of the molecular mechanism underlying the effects of
BPPs from snake venom in the testicular physiology,
adding new biological features to the whole venom.
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